Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mckesson Corp. (DE:MCK)
FRANKFURT:MCK
McKesson (MCK) Stock Price & Analysis
2 Followers
MCK Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€317.26 - €499.90
Previous Close€487.5
Volume2.00
Average Volume (3M)18.00
Market Cap
€63.92B
Enterprise Value€69.56B
Total Cash (Recent Filing)$1.98B
Total Debt (Recent Filing)$7.61B
Price to Earnings (P/E)N/A
Beta-0.13
Next Earnings
May 07, 2024EPS Estimate
€5.99Next Dividend Ex-DateN/A
Dividend Yield0.46%
Share Statistics
EPS (TTM)N/A
Shares Outstanding131,408,286
10 Day Avg. Volume5
30 Day Avg. Volume18
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)-4.89
Price to Sales (P/S)0.24
Price to Cash Flow (P/CF)68.00
P/FCF Ratio106.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.23
Enterprise Value/Gross Profit5.63
Enterprise Value/Ebitda15.67
Forecast
1Y Price Target
€530.29Price Target Upside8.78% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14
McKesson News
Bulls Say, Bears Say
Bulls Say
Company TransformationMcKesson has successfully transformed into an enterprise healthcare services entity with a strong position in the pharma and non-acute care medical supply chain.
Earnings GuidanceMCK raised FY24 adjusted EPS guidance, reflecting confidence in the company's earnings potential.
Stock ValuationAnalyst raises the price target of the stock to $505, indicating a belief in the company's value growth.
Bears Say
Financial PerformanceThe lack of visibility into future impacts of the RAD bankruptcy is affecting the free cash flow guidance.
Market GrowthThe company is experiencing slowing growth in GLP-1s, which may contribute to a cautious outlook.
Operational ConcernsA bad debt provision of $515 million related to the RAD bankruptcy suggests potential operational concerns.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
1.52% Other Institutional Investors
98.48% Public Companies and
Individual Investors
MCK FAQ
What was Mckesson Corp.’s price range in the past 12 months?
Mckesson Corp. lowest stock price was €317.26 and its highest was €499.90 in the past 12 months.
What is Mckesson Corp.’s market cap?
Currently, no data Available
When is Mckesson Corp.’s upcoming earnings report date?
Mckesson Corp.’s upcoming earnings report date is May 07, 2024 which is in 12 days.
How were Mckesson Corp.’s earnings last quarter?
Mckesson Corp. released its earnings results on Feb 07, 2024. The company reported €7.29 earnings per share for the quarter, beating the consensus estimate of €6.633 by €0.657.
Is Mckesson Corp. overvalued?
According to Wall Street analysts Mckesson Corp.’s price is currently Undervalued.
Does Mckesson Corp. pay dividends?
Mckesson Corp. does not currently pay dividends.
What is Mckesson Corp.’s EPS estimate?
Mckesson Corp.’s EPS estimate is €5.99.
How many shares outstanding does Mckesson Corp. have?
Currently, no data Available
What happened to Mckesson Corp.’s price movement after its last earnings report?
Mckesson Corp. reported an EPS of €7.29 in its last earnings report, beating expectations of €6.633. Following the earnings report the stock price went down -3.354%.
Which hedge fund is a major shareholder of Mckesson Corp.?
Among the largest hedge funds holding Mckesson Corp.’s share is Viking Global Investors LP. It holds Mckesson Corp.’s shares valued at 1B.
---
McKesson Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€530.29 (8.78% Upside)
€530.29 (8.78% Upside)
Blogger Sentiment
Bullish
DE:MCK Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
45.55%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
6.10%
Trailing 12-Months
Company Description
Mckesson Corp.
Incorporated in 1833, Texas-based McKesson Corp. provides pharmaceuticals, health information technology, medical supplies, and care management tools. The company operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions, International, and Medical-Surgical Solutions.
---
MCK Company Deck
---
MCK Earnings Call
Q3 2024
0:00 / 0:00
---
MCK Revenue Breakdown
86.96% U.S. Pharmaceutical
7.44% International
4.02% Medical-Surgical Solutions
1.59% Prescription Technology Solutions
---
MCK Stock 12 Months Forecast
Average Price Target
€530.29
▲(8.78% Upside)
Technical Analysis
McKesson
―
Cardinal Health
―
CVS Health
―
Walgreens Boots Alliance
―
GoodRx Holdings
―
Best Analysts Covering MCK
1 Year
1 Year Success Rate
14/16 ratings generated profit
1 Year Average Return
+34.66%
initiated a buy rating 2 months ago
Copying Michael Cherny's trades and holding each position for 1 Year would result in 87.50% of your transactions generating a profit, with an average return of +34.66% per trade.
---